Join CancerNetwork’s Integrative Oncology Tweet Chat

Article

CancerNetwork® will be hosting a tweet chat this Monday, November 16th, at 12 PM EST, that will feature real patient cases regarding the use of integrative oncology.

Join CancerNetwork® on Twitter this Monday, November 16th, at 12 PM EST, for a tweet chat on integrative oncology.

This discussion will feature real patient cases and present various treatment options for review, giving participants the opportunity to select what they believe is the best option for treatment.

The chat will be led by Linda E. Carlson, PhD, RPsych, the Enbridge Research Chair in Psychosocial Oncology, professor of Psychosocial Oncology in the department of Oncology in the Cumming School of Medicine at the University of Calgary, and adjunct professor in the Department of Psychology at the University of Calgary. Additionally, Carlson is also the director of Research and works as a clinical psychologist in the department of Psychosocial Resources at the Tom Baker Cancer Centre.

To participate in the chat, just follow the directions below.

integrative oncology tweet chat how to

tweet chat how to

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.